Increasing HIV transmission through male homosexual and heterosexual contact in Australia: results from an extended back-projection approach

Size: px
Start display at page:

Download "Increasing HIV transmission through male homosexual and heterosexual contact in Australia: results from an extended back-projection approach"

Transcription

1 DOI: /j x r 2010 British HIV Association HIV Medicine (2010), 11, ORIGINAL RESEARCH Increasing HIV transmission through male homosexual and heterosexual contact in Australia: results from an extended back-projection approach H Wand, 1 P Yan, 2 D Wilson, 1 A McDonald, 1 M Middleton, 1 J Kaldor 1 and M Law 1 1 National Centre in HIV Epidemiology and Clinical Research, Sydney, Australia and 2 Center for Infectious Disease Prevention and Control Population and Public Health Branch, Ottawa, Canada Objectives The aim of the study was to reconstruct the HIV epidemic in Australia for selected populations categorized by exposure route; namely, transmission among men who have sex with men (MSM), transmission among injecting drug users (IDUs), and transmission among heterosexual men and women in Australia. Design Statistical back-projection techniques were extended to reconstruct the historical HIV infection curve using surveillance data. Methods We developed and used a novel modified back-projection modelling technique that makes maximal use of all available surveillance data sources in Australia, namely, (1) newly diagnosed HIV infections, (2) newly acquired HIV infections and (3) AIDS diagnoses. Results The analyses suggest a peak HIV incidence in Australian MSM of 2000 new infections per year in the late 1980s, followed by a rapid decline to a low of o500 in the early 1990s. We estimate that, by 2007, cumulatively MSM were infected with HIV, of whom 13% were not diagnosed with HIV infection. Similarly, a total of 1050 and 2600 individuals were infected through sharing needles and heterosexual contact, respectively, and in 12% and 23% of these individuals, respectively, the infection remained undetected. Discussion Male homosexual contact accounts for the majority of new HIV infections in Australia. However, the transmission route distribution of new HIV infections has changed over time. The number of HIV infections is increasing substantially among MSM, increasing moderately in those infected via heterosexual exposure, and decreasing in IDUs. Keywords: Australia, HIV/AIDS, incidence, modified back-projection, transmission route Accepted 29 September 2009 Introduction Estimates of past and current HIV and AIDS incidences and prevalences are important for effective public health prevention strategies. The HIV/AIDS epidemic in Australia has been under surveillance since 1981 through notification of AIDS diagnoses, and since 1985 through notification of cases of newly diagnosed HIV infection. Since 1991, Correspondence: Dr Handan Wand, National Centre in HIV Epidemiology and Clinical Research, Sydney, Australia. Tel: ; Fax: ; hwand@nchecr.unsw.edu.au further surveillance has been supplemented by national notification of HIV diagnoses with evidence of newly acquired HIV infection, defined as new HIV diagnoses with either a previous negative HIV test within 12 months, or evidence of a recent seroconversion illness. Although these data are indicative of trends in the HIV epidemic, they cannot be used directly to estimate the incidence of HIV infection. Accurate estimates of the incidence of HIV infection are required at the national and subgroup levels to determine trends in the epidemic and to evaluate the effectiveness of prevention strategies. 395

2 396 H Wand et al. Methods based on back-projection [1] have historically been used to estimate the incidence of HIV infection (numbers of new infections per year) from AIDS surveillance data, based on the probability distribution of the incubation period, that is, the time from HIV infection to AIDS. The availability of effective antiretroviral therapies from 1997 onwards altered the distribution of the incubation period in ways that are difficult to quantify. The interpretation of trends in both AIDS case reporting and HIV infection reporting must take into account the effect of treatment in slowing disease progression and the effect of test-seeking behaviour on the numbers and characteristics of persons being tested for HIV. When monotherapy was the main treatment option, models of the epidemic were adjusted for estimates of its effect on the incubation period from infection to AIDS, but the complexities and stronger effects of the multiple therapies now available have made treatment adjustment too uncertain for use in the modelling. Methods of estimating HIV incidence rates based on the results of the HIV test and a test for a biomarker have been under investigation [2 4]. Although these methods provide a very up-to-date and revealing snapshot of the epidemic, the technology used to detect recent infections is still quite new and expensive. The methodology that we used in this study does not require a test for a biomarker and makes maximal use of all available HIV/AIDS data sources in Australia s surveillance databases, including newly diagnosed HIV infections, newly acquired HIV infections and AIDS diagnoses, to estimate trends in HIV incidence. As there is no established statistical model to link HIV incidence to HIV diagnosis with respect to HIV testing patterns, the current methodology assumed that, if an individual was infected before, or during, a certain year, it was more likely that this individual sought an HIV diagnostic test at the onset of clinical symptoms. However, as HIV testing became more widely available and promoted, individuals infected in later years tended to be more likely to seek testing independent of the onset of clinical symptoms. Surveillance systems based on the reporting of AIDS cases also do not provide a completely up-to-date picture of the trend of the HIV epidemic, highlighting the need for methods with which to estimate the incidence of HIV infection accurately. In recent years in Australia, there have been increasing numbers of HIV diagnoses in some states and territories, particularly among men who have sex with men (MSM) [5]. In this study, we used modified back-projection modelling to estimate the incidence of HIV infection in an attempt to assess whether increases in HIV notifications in recent years truly reflect increases in the underlying incidence of HIV infection. We investigated the three exposure routes with the highest incidences of HIV infection, namely: (1) transmission in MSM, including those who also reported injecting drug use (IDU), and including men with HIV infections without a reported source of HIV exposure; (2) transmission in people who reported IDU but not MSM; and (3) heterosexual transmission in men and women. These subgroup analyses are of particular importance in assessing the success of prevention programmes, and for the allocation of prevention resources. The coupling of the methodology used in this study with a long-established HIV/AIDS database created a unique opportunity to reconstruct the HIV infection curve. Methods Surveillance data In Australia, HIV transmission is monitored through the notification of cases of newly diagnosed HIV infection, including cases with evidence of newly acquired HIV infection, which is defined as HIV infection with evidence of a prior negative test or a diagnosis of primary HIV infection or an indeterminate western blot within 12 months of HIV diagnosis. Therefore, there are potentially three data sources available in each calendar year: HIV surveillance data (first HIV-positive diagnoses by year of diagnosis), data on newly acquired HIV infections (recent infections among new HIV diagnoses) and AIDS case reporting surveillance data (based on physicians reporting on diagnoses of clinical events subject to the AIDS case definition) [5]. Modified back-projection approach The back-projection method was originally proposed by Brookmeyer and Gail and used in Western countries in the late 1980s and early 1990s to estimate trends in HIV infections based on reported AIDS diagnoses [1]. This methodologyuseddataonreportedaidscases,combinedwithan assumption of the rate at which people progress from HIV infection to AIDS diagnosis (the incubation period), to estimate the most likely pattern of past HIV incidence. The availability of effective antiretroviral therapies from 1997 onwards altered the distribution of the incubation period in ways that are difficult to quantify. As a result, application of the method to current AIDS diagnosis data is unlikely to give reliable estimates of HIV infection rates. Some researchers [6] have modified the incubation function to account for the treatment effect, but this approach has generally been unsuccessful because of the difficulty of capturing the complexity of treatment regimens and their effects. Others [7] have incorporated HIV diagnosis data into the back-projection method to improve the reliability of estimation.

3 Increasing HIV transmission in Australia 397 The back-projection method that we used in this study differs from similar approaches in the literature, in that it does not require data linkage between the HIV and AIDS diagnostic registries. It is based on a parametric formulation of the time between the acquisition of HIV infection and the earliest diagnosis of HIV infection obtained from enhanced HIV surveillance systems or from laboratoryconfirmed testing. For an infected individual, a diagnosis of HIV infection may be made as a consequence of an awareness of recent exposure, the onset of symptoms related to HIV disease progression, random detection or frequent testing. In this study we assumed a simplified model that only involves two testing forces: testing during asymptomatic infection and testing driven by clinical symptoms at a late stage of HIV disease progression. Based on these assumptions, two submodels were constructed that are mathematically connected to form the combined progression rate distribution. The HIV incidence curve was then reconstructed by combining two back-projection estimated HIV incidence curves from AIDS diagnostic data (up to 1994, prior to which effective antiretroviral treatment was not available) and HIV diagnostic data using the combined progression rate distribution. The methodology also used the back-calculated HIV incidence to forecast what the trend of AIDS diagnoses over the years would have been in the absence of treatments. This forecast can be compared with the actual trend of AIDS diagnoses from surveillance data. Details of this methodology are given in the Appendix A. User-friendly software for this methodology, written in the R language, together with other technical and methodological documents, is available upon request (ping_yan@ phac-aspc.gc.ca). Results Following a long-term decline, the annual number of new HIV diagnoses has gradually increased recently, from 763 cases in 2000 to 998 in Among the cases of newly diagnosed HIV infection, an increasing number were in people who had acquired HIV infection within the previous year. Summary figures suggest that, by the end of 2006, diagnoses of HIV infection, diagnoses of AIDS and 6723 deaths following AIDS occurred in Australia [5]. Table 1 shows the distribution of HIV diagnoses for three exposure categories. Estimated HIV incidence curves and their pointwise 95% confidence intervals (CIs), which were calculated by bootstrap [7], are plotted for the three main routes of transmission (MSM, IDU and heterosexual acquired for both men and women) in Fig. 1a d. Model-predicted HIV and AIDS diagnoses (in the absence of therapies) along Table 1 HIV diagnoses in Australia over time and by likely route of exposure Exposure category MSM IDU Male heterosexual contact Source: Australian Surveillance Report, IDU, injecting drug use; MSM, men who have sex with men. Female heterosexual contact with their observed counts are also presented in Figs 2a d and 3a d, respectively. In recent years there has been a noticeable increase in the number of HIV diagnoses in MSM (Fig. 2a). The backprojection analyses suggest a peak HIV incidence in MSM of over 2000 new infections per year in the early 1980s, followed by a rapid decline to a low of a little under 500 new infections per year in the early 1990s (Fig. 1a). It is estimated that the incidence of HIV infection then increased gradually through the early 2000s, to 750 new HIV infections in This is in broad agreement with previous reports and conventional back-projection estimates [8]. Our results also show that, to the end of 2006, a total of men were infected with HIV through male homosexual sex, of whom 13% (95% CI 12%, 14%) are estimated not to have been diagnosed with HIV infection (Table 2). In , approximately 4% of HIV diagnoses in Australia were in people who reported a history of IDU (Annual Surveillance Report, 2007). The prevalence of HIV infection among people attending needle and syringe programmes remained low ( 1% in ). According to the back-projection estimates, there was a peak in the incidence of HIV infection through IDU of 122 new infections in 1985, followed by a rapid decline to a low of 9 new infections in 1994 (Fig. 1b). The back-projections suggest some evidence of an increase in HIV incidence in the late 1990s, but a plateau at around 40 HIV infections per year in the 2000s. The models estimate that a total of 1050 people were infected with HIV solely through IDU in Australia to the end of 2006, of whom 12% (95% CI 9%, 15%) are estimated to have remained undiagnosed (Table 2). The number of new HIV diagnoses for which exposure to HIV was attributed to heterosexual contact increased from 775 in to 914 in , accounting for

4 398 H Wand et al. Estimated HIV infections 3500 (a) Estimated HIV infections (b) Estimated HIV infections 120 (c) Estimated HIV infections 100 (d) Fig. 1 The estimated number of HIV infections ( ) and uncertainty bands (0.975 and quintiles) ( ) by year according to the backprojection model for Australian (a) men who have sex with men, (b) injecting drug users, (c) heterosexual men and (d) heterosexual women. Fig. 2 The estimated number of HIV diagnoses by model ( ) and observed HIV diagnoses ( ) by year for Australian (a) men who have sex with men, (b) injecting drug users, (c) heterosexual men and (d) heterosexual women.

5 Increasing HIV transmission in Australia 399 Fig. 3 The estimated number of AIDS cases by model(assumingnotreatmenteffect)( ) and observed AIDS diagnoses (which may be subject to a treatment effect) ( ) by year for Australian (a) men who have sex with men, (b) injecting drug users, (c) heterosexual men and (d) heterosexual women. Table 2 Back-projected number of HIV infections in men who have sex with men (MSM), injecting drug users (IDU) and those infected via heterosexual transmission, and estimated percentage of infections not diagnosed in the time periods before 1990, and Model-based estimates for back-projected HIV infections Before Total MSM Estimated number of HIV infections Percentage of infections not yet diagnosed (95% CI) 2 (1.0, 3.0) 9 (8.0, 10.0) 43 (41.5, 44.4) 13 (12.0, 14.0) IDU Estimated number of HIV infections Percentage of infections not yet diagnosed (95% CI) 3 (1.6, 4.4) 1 (0.4, 2.4) 36 (29.7, 42.3) 12 (9, 15) Heterosexual male Estimated number of HIV infections Percentage of infections not yet diagnosed (95% CI) 2 (0.8, 3.2) 10 (7, 13) 52 (48, 56) 23 (21, 25) Heterosexual female Estimated number of HIV infections Percentage of infections not yet diagnosed (95% CI) 2 (0.5, 3.5) 9 (6, 12) 52 (47, 57) 22 (19, 25) CI, confidence interval. 20% of the total HIV diagnoses (Annual Surveillance Report, 2007). Consistent with these results, back-projection analyses suggest steady increases in new infections attributed to heterosexual exposure to HIV (men and women) since the mid-1990s (Fig. 1c and d, respectively). The model estimates that a total of 1492 men and 1119

6 400 H Wand et al. women were infected through heterosexual exposure, of whom 23% (95% CI 21%, 25%) and 22% (95% CI 19%, 25%), respectively, are yet to be diagnosed with HIV infection (Table 2). Discussion In the absence of accurate tests for biological markers that can be used to determine the duration of infection in individuals, it is important to use all data available to estimate trends in HIV incidence over time. One of the advantages of our model for estimating HIV incidence is its ability to utilize the long history of HIV and AIDS surveillance data while adjusting for changes in testing behaviours. AIDS surveillance data were only used in the analysis for HIV incidence until 1987, just prior to the first antiretroviral drug becoming available. Overall, our results suggest that recent increases in HIV diagnoses in MSM in Australia do reflect an increasing trend in underlying HIV incidence over recent years. Similar increases in HIV diagnoses have been seen in MSM in virtually all developed countries [9]. Deterministic mathematical models suggest that reported increases in unprotected anal intercourse in MSM, and importantly increases in other sexually transmissible infections acting as co-factors for HIV transmission, can explain increases in HIV incidence in Australia [10]. According to our results, the rate of HIV transmission through IDU is currently relatively flat in Australia after an increase in incidence during the late 1990s. The increase in HIV incidence in the late 1990s coincided with an increase in the number of injecting drug users, and with an increase in the incidence of hepatitis C virus (HCV) infection [11]. It is widely acknowledge that, since 2001 in Australia, there has been a reduction in the heroin supply, resulting in some reduction in IDU, and also an estimated decline in HCV incidence [12]. The plateau in HIV incidence during the 2000s may reflect these patterns of reduced IDU, and also raises the possibility that HIV transmission among injecting drug users could re-emerge if the number of injecting drug users increased. An important finding from our analyses is a consistent pattern of increasing estimated HIV incidence in men and women with heterosexual exposure (Fig. 1c and d, respectively), despite relatively inconclusive trends in HIV diagnoses (Fig. 2c and d, respectively). As far as can be ascertained using national surveillance data, the majority of reported diagnoses are either in people from a high HIV prevalence country, or in people with a partner from a high HIV prevalence country. However, a relatively large proportion of HIV infections among heterosexuals are estimated to be undiagnosed. Although these estimates are still much lower than those in other developed countries, combined with increases in reported sexually transmissible infections in the general population [5], these increases in estimated HIV incidence are a real concern. This raises the possibility of an accelerating heterosexually transmitted HIV epidemic in Australia, which has to date largely been avoided. This study is the first to use a modified back-projection method to reconstruct the HIV infection curves for selected populations by linking three data sources in the Australian surveillance database. Previously we investigated the Australian HIV epidemic through the development and analysis of a mathematical transmission model [10] which uses a mechanistic framework to combine epidemiological, behavioural, biological and clinical data, and assess how factors interact and together contribute to the HIV incidence in Australian MSM. One advantage of the backprojection analyses used in this study is that they provide a completely independent statistical method for estimating HIV incidence, the results of which can be compared with those obtained using mathematical transmission models. Both the statistical back-projection models and the epidemic mathematical models are based on a number of uncertain, but different, assumptions. The extent to which these very different approaches agree provides some corroboration of the results. The back-projection analyses do have limitations, chiefly in the assumptions required to generate a rate of progression from HIV infection to diagnosis. Although this rate of progression was allowed to vary over time, this was assumed to be in a fairly strictly increasing manner. This assumption is consistent with testing data for MSM in Australia, where the proportion tested each year has increased over time; in the absence of similar data for heterosexuals, this assumption is not unreasonable. Furthermore, although the relationship among newly acquired HIV infection, HIV diagnosis and AIDS diagnosis (until 1987) is to some extent exploited in generating the progression rate distribution, it is not possible for external information, for example rates of HIV testing, to be built into the models using the current formulation. It is also a well-known limitation of back-projection analyses that estimates of recent HIV incidence, the period that is of most interest, are highly uncertain. The methodology used in this study has several advantages over the original back-projection method which was based purely on AIDS data [5]. First, this method utilizes data available from an established national surveillance system and maximizes the available information to estimate the HIV incidence. Secondly, this approach was able to reproduce the historical trend in HIV infection and the results were broadly consistent with the observed pattern of HIV diagnoses in all exposure groups. Publicly available user-friendly software written in the R language and a user manual describing the

7 Increasing HIV transmission in Australia 401 method used in this study are available upon request from the second author. Conclusion In conclusion, these analyses may help to improve understanding of the dynamics of the HIV epidemic, based on high-quality surveillance data, and provide reasonably reliable estimates of the incidence of HIV infection. Our analyses suggest some increase in HIV transmission through male homosexual and heterosexual contact in Australia in the early 2000s, although not through IDU. This suggests that educational messages around safe sex need to be reinforced. Acknowledgements The National Centre in HIV Epidemiology and Clinical Research (NCHECR) is funded by the Australian Government Department of Health and Ageing, and is affiliated with the Faculty of Medicine, University of New South Wales, Sydney, NSW. Its work is overseen by the Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis. The NCHECR Surveillance Programme is a collaborating unit of the Australian Institute of Health and Welfare. Competing interests The authors have no conflict of interest. Authors contributions Study concept and design: HW and ML. Analysis and interpretation of data: HW, ML and DW. Data extraction: HW, AM and MM. Drafting of the manuscript: HW and ML. Critical revision of the manuscript for important intellectual content: all authors. NSW: National Centre in HIV Epidemiology and Clinical Research (NCHECR), The University of New South Wales, Munoz A, Hoover DR. Role of cohort studies for evaluating AIDS therapies. In: Finkelstein DM, Schoenfeld DA, eds. AIDS Clinical Trials. New York: Wiley, 1995: Cui J, Becker NG. Estimating HIV incidence using dates of both HIV and AIDS diagnoses. Stat Med 2000; 19: Feachem RGA. Valuing the Past... Investing in the Future: Evaluation of the National HIV/AIDS Strategy to , 2nd ed. Downer, ACT: Looking Glass Press for Publications and Design (Public Affairs), Commonwealth Dept. of Human Services and Health, Grulich AE, Kaldor JM. Trends in HIV incidence in homosexual men in developed countries. Sexual Health 2008; 5: Hoare A, Wilson DP, Regan DG, Kaldor J, Law MG. Using mathematical modelling to help explain the differential increase in HIV incidence in New South Wales, Victoria and Queensland: importance of other sexually transmissible infections. Sexual Health 2008; 5: HCVPWG. Estimates and Projections of the Hepatitis C Virus Epidemic in Australia Sydney, NSW: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Razali K, Thein HH, Bell J et al. Modelling the hepatitis C virus epidemic in Australia. Drug Alcohol Depend 2007; 91: Brookmeyer R, Gail MH. Generalized back-calculation: extension to account for nonstationary incubation distributions. In: AIDS Epidemiology: A Quantitative Approach. New York: Oxford University Press, 1994: Becker NG, Watson LF, Carlin JB. A method of non-parametric back-projection and its application to AIDS data. Stat Med 1991; 10: References 1 Brookmeyer R, Gail MH. Minimum size of the acquired immunodeficiency syndrome (AIDS) epidemic in the United States. Lancet 1986; 2: Brookmeyer R, Quinn TC. Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. Am J Epidemiol 1995; 141: Janssen RS, Satten GA, Stramer SL et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998; 280: Karon JM, Song R, Brookmeyer R, Kaplan EH, Hall HI. Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test result. Stat Med 2008; 27(23): NCHECR. HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report. Sydney, Appendix A The approach we used in this study is based on the assumption that all people infected with HIV will eventually be diagnosed with HIV, either close to infection and be reported as having a newly acquired HIV infection, later during chronic HIV infection and be notified as a new HIV diagnosis, or much later during infection at the onset of clinical symptoms (AIDS). This assumption was modelled using the following submodels. Submodel 1: HIV testing during asymptomatic infection It is assumed that a proportion of people infected with HIV will be diagnosed with HIV prior to clinical symptoms or AIDS. A heterogeneous mixed exponential model was used to model the rate at which people in this group are diagnosed with HIV. Each individual in this group was

8 402 H Wand et al. assumed to have a constant testing rate l, corresponding to an exponential model with probability density function (p.d.f.) f a ðxjlþ ¼le lx for a given l. We also assume heterogeneity such that the testing rate l itself varies across individuals. We let l follow a standard exponential distribution with p.d.f., gðlþ ¼e l. This leads to a mixed exponential model R 1 0 f aðxjlþgðlþdl ¼ 1=ðx þ 1Þ 2 which is the p.d.f of the Pareto distribution for the duration X between HIV infection and HIV diagnosis, which essentially steps down over time. Then the corresponding survivor and hazard functions will be: S a ðxþ ¼PrfX > xg ¼ 1 1 þ x and h aðxþ ¼ 1 ð1þ 1 þ x We define the probability of testing x years after infection as follows: f a ðxþ ¼S a ðxþ S a ðx þ 1Þ ¼1=ðx þ 2Þðx þ 1Þ; x ¼ 0; 1; 2;... Submodel 2: HIV testing driven by clinical symptoms at a late stage of HIV disease progression A proportion of HIV diagnoses are assumed to be made at a late stage of HIV infection, essentially as a result of clinical symptoms close to, or at, AIDS diagnosis. For this group, we assumed that the progression from HIV infection to the earliest HIV diagnosis follows a distribution similar to the progression to CD4 counts of o200 cells/ml without any treatment. A Weibull distribution was used, with median time to HIV diagnosis of 6.5 years and shape parameter 2.08 [13] with the following survivor and hazard functions: S b ðxþ ¼expf 0:014x 2:08 g and h b ðxþ ¼0:029x 1:08 ð2þ We define the probability of testing x years after infection as follows: f b ðxþ ¼S b ðxþ S b ðx þ 1Þ ¼ expf 0:014x 2:08 g expf 0:014ðx þ 1Þ 2:08 g; x ¼ 0; 1; 2;... The Weibull distribution has the property that the hazard increases with increasing time from infection, which intuitively would mirror the risk of progression to HIVrelated symptoms in untreated HIV infection. Overall rate of progression to HIV diagnosis The overall rate of progression to HIV diagnosis f ðxjt; jþ was then formulated based on combining the two submodels [i.e. f a (x) and f b (x)] described above by using a mixture distribution model as follows: f ðxjt; jþ ¼Sðxjt; jþ Sðx þ 1jt; jþ where Sðxjt; jþis the survival function: Sðxjt; jþ ¼m t ðjþs a ðxþþ½1 m t ðjþšs b ðxþ ð3þ where m t ðjþ ¼ pedþgðt t 0 Þ ; t t 1þe dþgðt t 0 Þ 0, is a mixing function with j 5 (p,d,g); p represents the proportion of infected individuals who were not tested because of clinical symptoms; d determines the overall shape of the curves and g denotes the rate of increase in infection at time t. When HIV testing became available at t 5 t 0, m t0 ðjþ ¼ ped,asm 1þe d t (j) increases with time t at rate l to a saturation level p ¼ lim t!1 m t ðjþ. We assume that there will be a proportion 1 p of infected individuals who are driven by clinical symptoms to be tested (as specified by submodel 2). The parameter d determines the overall shape of the curves. Prior to the availability of HIV testing in 1985, HIV diagnosis was only made on the basis of AIDS symptoms. This information was incorporated into our model by allowing the model to vary over time, so that the proportion of diagnoses resulting from clinical symptoms would decrease after Therefore, the mixture distribution, f ðxjt; jþ, results in an overall bath-tub shaped hazard, with a relatively high rate of HIV diagnosis in the first year following HIV infection, which then decreases over time, before increasing again as clinical symptoms appear. The two submodels given by (1) and (2) are then mathematically connected based on HIV diagnostic data. For this purpose, we first define the following distribution functions by using (3): Fðtjt; jþ ¼1 Sðtjt; jþ ¼ PrfHIV diagnosed during ðt; t þ tšj HIV infection at time t; jg and rðtjtþ ¼Prfinfection in ½t t; tþjdiagnosis at time tg where Fðtjt; jþ is the distribution of time to testing and r(t t) is the distribution of time since infection. For small t, one has the approximation rðtjtþi 2 ðtþ i 1 ðtþfðtjtþ, implying that the number of individuals who are infected and diagnosed during a short duration of time t around the infection time t. Therefore, the back-calculation predicts ~rðtjt; jþ ¼ ~ i 1 ðt; jþ Fðtjt; jþ: ~i 2 ðt; jþ The data on recent infections (k t ) among newly diagnosed individuals (n t ) were used to identify the parameters in j. As the pair (k t, n t ) follows a binomial distribution, the likelihood function for j can be written as Lðjj~i 1 ðt; jþþ ¼ ~rðtjt; jþ kt nt kt ½1 ~rðtjt; jþš ð4þ The expectation-maximization-smoothing (EMS) algorithm [14] is used to back-calculate the HIV incidence from HIV diagnostic data and determine the final estimate for the

9 Increasing HIV transmission in Australia 403 HIV incidence. For observed values of (k t, n t ), the methodology searches all possible values in the parameter space for j 5 (p, d, g) togeneratethe~rðtjt; jþ that most closely agrees with the observed proportion kt n t. This also implies that, for each combination of (p, d, g) in the parameter space, the following back-calculations are made in order to determine the final incidence, ^iðtþ ¼~i 1 ðt; ^jþ, (i) based on AIDS diagnostic data and (ii) based on HIV diagnostic data by searching the set of parameters ^j until (3) is maximized (details are omitted).

Estimates of HIV Prevalence and Incidence in Canada, 2011

Estimates of HIV Prevalence and Incidence in Canada, 2011 Estimates of HIV Prevalence and Incidence in Canada, 2011 Surveillance and Epidemiology Division Professional Guidelines and Public Health Practice Division Centre for Communicable Diseases and Infection

More information

Annual Surveillance Report 2014 Supplement

Annual Surveillance Report 2014 Supplement HIV in Australia Annual Surveillance Report 2014 Supplement Main findings A total of 1 236 cases of HIV infection were newly diagnosed in Australia in 2013, similar to levels in 2012 when the number of

More information

Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander people: Annual Surveillance Report

Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander people: Annual Surveillance Report Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander people: Annual Surveillance Report 214 The Kirby Institute for infection and immunity in society 214 ISSN 1835

More information

Appendix NEW METHOD FOR ESTIMATING HIV INCIDENCE AND TIME FROM INFECTION TO DIAGNOSIS USING HIV SURVEILLANCE DATA: RESULTS FOR FRANCE

Appendix NEW METHOD FOR ESTIMATING HIV INCIDENCE AND TIME FROM INFECTION TO DIAGNOSIS USING HIV SURVEILLANCE DATA: RESULTS FOR FRANCE Supporting document 1 Appendix NEW METHOD FOR ESTIMATING HIV INCIDENCE AND TIME FROM INFECTION TO DIAGNOSIS USING HIV SURVEILLANCE DATA: RESULTS FOR FRANCE Ndawinz JDA 1,2, Costagliola D 1,2,3 and Supervie

More information

State of Alabama HIV Surveillance 2014 Annual Report

State of Alabama HIV Surveillance 2014 Annual Report State of Alabama HIV Surveillance 2014 Annual Report Prepared by: Division of STD Prevention and Control HIV Surveillance Branch Contact Person: Richard P. Rogers, MS, MPH richard.rogers@adph.state.al.us

More information

HIV/AIDS Epi Update Public Health Agency of Canada

HIV/AIDS Epi Update Public Health Agency of Canada 1 HIV/AIDS Epi Update Public Health Agency of Canada www.phac-aspc.gc.ca/hast-vsmt/ JULY 21 National HIV Prevalence and Incidence Estimates in Canada for 28 At a Glance More Canadians are living with HIV

More information

UNGASS COUNTRY PROGRESS REPORT

UNGASS COUNTRY PROGRESS REPORT UNGASS COUNTRY PROGRESS REPORT AUSTRALIA For the period January 2008 December 2009 1 of 16 I. Table of Contents Page * I. Table of Contents... 1 II. Status at a glance... 2 III. Overview of the HIV/AIDS

More information

Decreasing rates of Kaposi's sarcoma and non-hodgkin's lymphoma in the era of potent combination antiretroviral

Decreasing rates of Kaposi's sarcoma and non-hodgkin's lymphoma in the era of potent combination antiretroviral CONCISE COMMUNICATION Decreasing rates of Kaposi's sarcoma and non-hodgkin's lymphoma in the era of potent combination antiretroviral therapy Andrew E. Grulich, Yueming Li, Ann M. McDonald, Patricia K.

More information

A note on Australian AIDS survival

A note on Australian AIDS survival A note on Australian AIDS survival B.D. Ripley 1 and P.J. Solomon 2 1. Department of Statistics, University of Oxford, 1 South Parks Road, Oxford OX1 3TG, UK 2. Department of Statistics, University of

More information

Hepatitis B and C in Australia. Annual Surveillance Report Supplement 2016

Hepatitis B and C in Australia. Annual Surveillance Report Supplement 2016 Hepatitis B and C in Australia Annual Surveillance Report Supplement 216 The Kirby Institute for infection and immunity in society 216 ISSN 226-163 (Online) This publication is available at Internet address

More information

State of Alabama HIV Surveillance 2013 Annual Report Finalized

State of Alabama HIV Surveillance 2013 Annual Report Finalized State of Alabama HIV Surveillance 2013 Annual Report Finalized Prepared by: Division of STD Prevention and Control HIV Surveillance Branch Contact Person: Allison R. Smith, MPH Allison.Smith@adph.state.al.us

More information

Overview. HIV and the First Peoples of Australia Our Story, Our Time, Our Journey. Social Determinants of Health. Our Story Education.

Overview. HIV and the First Peoples of Australia Our Story, Our Time, Our Journey. Social Determinants of Health. Our Story Education. HIV and the First Peoples of Australia Our Story, Our Time, Our Journey Friday 18th July, 2014 Sydney Associate Professor James Ward Baker IDI Deputy Program Head, Aboriginal and Torres Strait Islander

More information

Annual Statistical Update: HIV and AIDS

Annual Statistical Update: HIV and AIDS Annual Statistical Update: HIV and AIDS 2015 Data reported to December 31, 2015 Epidemiology & Surveillance Public Health Branch Public Health and Primary Health Care Division Manitoba Health, Seniors

More information

Epidemiological and economic impact of potential increased hepatitis C treatment uptake in Australia

Epidemiological and economic impact of potential increased hepatitis C treatment uptake in Australia Epidemiological and economic impact of potential increased hepatitis C treatment uptake in Australia 2010 2010 ISBN 978 0 7334 2892-0 This publication is available at Internet address http://www.nchecr.unsw.edu.au

More information

Supplement for: CD4 cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, gender and calendar time.

Supplement for: CD4 cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, gender and calendar time. Supplement for: CD4 cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, gender and calendar time. Anne Cori* 1, Michael Pickles* 1, Ard van Sighem 2, Luuk Gras 2,

More information

Victorian AIDS Council Gay Men s Health Centre

Victorian AIDS Council Gay Men s Health Centre Victorian AIDS Council Gay Men s Health Centre including the Positive Living Centre VAC Reg. No. A 3609 GMHC Reg No. A0010550F VAC ABN 52 907 644 835 GMHC ABN 87 652 472 253 AUSTRALIAN GOVERNMENT DEPARTMENT

More information

Estimation for the infection curves for the spread of Severe Acute Respiratory. Syndrome (SARS) from a back-calculation approach

Estimation for the infection curves for the spread of Severe Acute Respiratory. Syndrome (SARS) from a back-calculation approach Estimation for the infection curves for the spread of Severe Acute Respiratory Syndrome (SARS) from a back-calculation approach Ping Yan Modelling and Projection Section Centre for Infectious Disease Prevention

More information

HIV in Australia Annual surveillance short report 2018

HIV in Australia Annual surveillance short report 2018 HIV in Australia Annual surveillance short report 218 The Kirby Institute for infection and immunity in society 218 ISSN 226-163 (Online) This publication and associated data are available at internet

More information

Estimates of New HIV Infections in the United States

Estimates of New HIV Infections in the United States Estimates of New HIV Infections in the United States CDC HIV/AIDS FACT S A UGUS T 28 Accurately tracking the HIV epidemic is essential to the nation s HIV prevention efforts. Yet monitoring trends in new

More information

National AIDS Registry

National AIDS Registry National AIDS Registry Table 1.1 Cases of AIDS and deaths following AIDS by sex and State/Territory in which diagnosis of AIDS was made, cumulative to 31 December 2006, and for two previous yearly intervals

More information

New Brunswick Report on Sexually Transmitted and Blood Borne Infections, 2016

New Brunswick Report on Sexually Transmitted and Blood Borne Infections, 2016 New Brunswick Report on Sexually Transmitted and Blood Borne Infections, 6 Table of Contents. Introduction.... Methodology... 3. Data Limitations.... Definitions used... 3 5. Overview of STBBI epidemiology

More information

FULTON COUNTY GOVERNMENT RYAN WHITE PART A PROGRAM. Atlanta Eligible Metropolitan Area HIV/AIDS Unmet Need Estimate

FULTON COUNTY GOVERNMENT RYAN WHITE PART A PROGRAM. Atlanta Eligible Metropolitan Area HIV/AIDS Unmet Need Estimate FULTON COUNTY GOVERNMENT RYAN WHITE PART A PROGRAM Atlanta Eligible Metropolitan Area HIV/AIDS Unmet Need Estimate Southeast AIDS Training and Education Center Department of Family and Preventative Medicine

More information

Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test results

Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test results STATISTICS IN MEDICINE Statist. Med. 2008; 27:4617 4633 Published online 4 August 2008 in Wiley InterScience (www.interscience.wiley.com).3144 Estimating HIV incidence in the United States from HIV/AIDS

More information

HIV and AIDS in Northern Inter- Tribal Health Authority

HIV and AIDS in Northern Inter- Tribal Health Authority HIV and AIDS in Northern Inter- Tribal Health Authority Summary report 25-215 Human immunodeficiency virus (HIV) is transmitted primarily high risk sexual behaviour, contaminated blood and body fluids,

More information

EDMA HIV-AIDS TEAM Fact Sheet November 2007

EDMA HIV-AIDS TEAM Fact Sheet November 2007 EDMA HIV-AIDS TEAM Fact Sheet November 2007 1. HIV Facts AIDS epidemic update UNAIDS Epidemic Update, November 2007 (1) 760,000 people to be living with HIV in Western and Central Europe in 2007. 31,000

More information

Backcalculating HIV incidence and predicting AIDS in Australia, Cambodia and Vietnam. Australia

Backcalculating HIV incidence and predicting AIDS in Australia, Cambodia and Vietnam. Australia Backcalculating HIV incidence and predicting AIDS in Australia, Cambodia and Vietnam The aim of today s practical is to give you some hands-on experience with a nonparametric method for backcalculating

More information

Receptive Anal Intercourse and HIV Infection

Receptive Anal Intercourse and HIV Infection World Journal of AIDS, 2017, 7, 269-278 http://www.scirp.org/journal/wja ISSN Online: 2160-8822 ISSN Print: 2160-8814 Receptive Anal Intercourse and HIV Infection Gilbert R. Lavoie 1, John F. Fisher 2

More information

Epidemiology of Acute Hepatitis C Infection in Canada Results from the Enhanced Hepatitis Strain Surveillance System (EHSSS)

Epidemiology of Acute Hepatitis C Infection in Canada Results from the Enhanced Hepatitis Strain Surveillance System (EHSSS) Epidemiology of Acute Hepatitis C Infection in Canada Results from the Enhanced Hepatitis Strain Surveillance System (EHSSS) At a Glance Reported rates of acute HCV declined from.5 per, population in to.

More information

Understanding HIV/AIDS: The current state of the HIV epidemic in British Columbia Mark Gilbert, MD, MHSc, FRCPC

Understanding HIV/AIDS: The current state of the HIV epidemic in British Columbia Mark Gilbert, MD, MHSc, FRCPC Understanding HIV/AIDS: The current state of the HIV epidemic in British Columbia Mark Gilbert, MD, MHSc, FRCPC STOP HIV/AIDS Provincial Expansion Knowledge Kick Off January 31, 2013 Learning objectives

More information

Government of Canada Federal AIDS Initiative Milestones

Government of Canada Federal AIDS Initiative Milestones HIV in Canada: Trends and Issues for Advancing Prevention, Care, Treatment and Support Through Knowledge Exchange Michael R Smith, Senior Policy Advisor, Programs and Coordination Division, Centre for

More information

Modelling HIV prevention: strengths and limitations of different modelling approaches

Modelling HIV prevention: strengths and limitations of different modelling approaches Modelling HIV prevention: strengths and limitations of different modelling approaches Leigh Johnson Centre for Infectious Disease Epidemiology and Research Background Models of HIV differ greatly in their

More information

Surveillance and epidemiology of blood borne viral hepatitis in Australia: 21 years of the National Notifiable Disease Surveillance System

Surveillance and epidemiology of blood borne viral hepatitis in Australia: 21 years of the National Notifiable Disease Surveillance System Surveillance and epidemiology of blood borne viral hepatitis in Australia: 21 years of the National Notifiable Disease Surveillance System Aleece MacPhail Alfred Health University of Melbourne Monash University

More information

Estimates of New HIV Infections in the United States

Estimates of New HIV Infections in the United States Estimates of New HIV Infections in the United States CDC HIV/AIDS FactS A u g u s t 28 Accurately tracking the HIV epidemic is essential to the nation s HIV prevention efforts. Yet monitoring trends in

More information

Bloodborne viral and sexually transmissible infections in Aboriginal and Torres Strait Islander people. Annual Surveillance Report 2017

Bloodborne viral and sexually transmissible infections in Aboriginal and Torres Strait Islander people. Annual Surveillance Report 2017 Bloodborne viral and sexually transmissible infections in Aboriginal and Torres Strait Islander people Annual Surveillance Report 217 5 5 214 214 213 213 212 216 212 216 215 215 214 214 214 213 213 212

More information

HIV Update For the Internist

HIV Update For the Internist HIV Update For the Internist Disclosures I declare that I have received no incentives, financial or otherwise, from pharmaceutical or biomedical companies relevant to the content of this talk. As an Infectious

More information

NATIONAL CENTRE IN HIV EPIDEMIOLOGY AND CLINICAL RESEARCH

NATIONAL CENTRE IN HIV EPIDEMIOLOGY AND CLINICAL RESEARCH NATIONAL CENTRE IN HIV EPIDEMIOLOGY AND CLINICAL RESEARCH ANNUAL REPORT 2001 Contents What is NCHECR? 1 Foreword 2 Research highlights 3 Teaching and training highlights 7 Service highlights 8 International

More information

Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander people: Surveillance and Evaluation Report

Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander people: Surveillance and Evaluation Report Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander people: Surveillance and Evaluation Report 211 The Kirby Institute for infection and immunity in society 211

More information

HIV EPIDEMIOLOGY IN NEW YORK CITY

HIV EPIDEMIOLOGY IN NEW YORK CITY HIV EPIDEMIOLOGY IN NEW YORK CITY Ellen Weiss Wiewel, MHS HIV Epidemiology and Field Services Program New York City Department of Health and Mental Hygiene http://www.nyc.gov/html/doh/html/dires/hivepi.shtml

More information

Developing and validating a risk scoring tool for chlamydia infection among sexual health clinic attendees in Australia

Developing and validating a risk scoring tool for chlamydia infection among sexual health clinic attendees in Australia Previous Versions Version 1: BMJ Open 2010 000005 Developing and validating a risk scoring tool for chlamydia infection among sexual health clinic attendees in Australia A simple algorithm to identify

More information

HIV surveillance in Northern Ireland 2016

HIV surveillance in Northern Ireland 2016 HIV surveillance in Northern Ireland 2016 Contents Page 1 Surveillance arrangements 3 2 Introduction and key points 4 3 Trend information 5 - New diagnoses Age and gender Route of transmission CD4 surveillance

More information

UNGASS COUNTRY PROGRESS REPORT SINGAPORE

UNGASS COUNTRY PROGRESS REPORT SINGAPORE UNGASS COUNTRY PROGRESS REPORT SINGAPORE Submission date: 14 March 2008 Reporting period: January 2006 December 2007 I. Overview of the HIV/AIDS epidemic Singapore is categorized as a low-prevalence epidemic.

More information

Mid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006

Mid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006 Mid-term Review of the UNGASS Declaration of Commitment on HIV/AIDS Ireland 2006 Irish Role in Global Response Just as the HIV/AIDS epidemic is a global threat, addressing the challenge of the epidemic

More information

National HIV Testing Policy 2006

National HIV Testing Policy 2006 National HIV Testing Policy 2006 2006 National HIV Testing Policy 1 2006 National HIV Testing Policy Table of Contents EXECUTIVE SUMMARY...3 INTRODUCTION...7 1) GUIDING PRINCIPLES FOR HIV TESTING IN AUSTRALIA...8

More information

HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012

HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012 HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012 Number of Cases Note: In this surveillance report, HIV cases include persons reported with HIV infection (non-aids), advanced HIV (non-aids) and AIDS within a

More information

Increase in syphilis testing and detection of early syphilis among men who have sex with men across Australia

Increase in syphilis testing and detection of early syphilis among men who have sex with men across Australia 6//26 Increase in syphilis testing and detection of early syphilis among men who have sex with men across Australia 27-24 Eric P.F. Chow,2, Denton Callander 3,4, Christopher K Fairley,2, Lei Zhang,2, Basil

More information

Ministry of Health. National Center for HIV/AIDS, Dermatology and STD. Report of a Consensus Workshop

Ministry of Health. National Center for HIV/AIDS, Dermatology and STD. Report of a Consensus Workshop Ministry of Health National Center for HIV/AIDS, Dermatology and STD Report of a Consensus Workshop HIV Estimates and Projections for Cambodia 2006-2012 Surveillance Unit Phnom Penh, 25-29 June 2007 1

More information

The epidemiology of hepatitis C in Canada

The epidemiology of hepatitis C in Canada The epidemiology of hepatitis C in Canada FACT SHEET Published 2017 This fact sheet provides a snapshot of the hepatitis C epidemic in Canada. It is one of a series of fact sheets providing epidemiological

More information

Supplementary Material. In this supplement we derive the full form of the monetary and health costs of testing

Supplementary Material. In this supplement we derive the full form of the monetary and health costs of testing Supporting document Supplementary Material In this supplement we derive the full form of the monetary and health costs of testing every years, and ; we derive the approximation shown in (1); and we justify

More information

Surveillance and Evaluation Report Edited by National Centre in HIV Epidemiology and Clinical Research

Surveillance and Evaluation Report Edited by National Centre in HIV Epidemiology and Clinical Research Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander people: Surveillance and Evaluation Report Edited by National Centre in HIV Epidemiology and Clinical Research

More information

Harm reduction among drug users in Spain

Harm reduction among drug users in Spain Harm reduction among drug users in Spain Luxemburg,, 27 October 21 Dr. José Manuel Arroyo Cobo Deputy Director General of Health in Prisons Ministry of Internal Affairs Dr. Tomás s Hernández ndez Fernández

More information

The epidemiology of HIV in Canada

The epidemiology of HIV in Canada FACTSHEET The epidemiology of HIV in Canada This fact sheet provides a snapshot of the HIV epidemic in Canada. It is one of a series of fact sheets on the epidemiology of HIV and hepatitis C in Canada.

More information

HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis

HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis Akbarzadeh et al. BMC Public Health (2016) 16:1216 DOI 10.1186/s12889-016-3887-y RESEARCH ARTICLE Open Access HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical

More information

STRATEGIES FOR MATERNO- FETAL TRANSMISSION OF HIV, HIV AND HBV COINFECTIONS IN CONSTANTA - ROMANIA

STRATEGIES FOR MATERNO- FETAL TRANSMISSION OF HIV, HIV AND HBV COINFECTIONS IN CONSTANTA - ROMANIA STRATEGIES FOR MATERNO- FETAL TRANSMISSION OF HIV, HIV AND HBV COINFECTIONS IN CONSTANTA - ROMANIA Simona Claudia CAMBREA MD, Ph D Faculty of Medicine, Ovidius University, Constanta, Romania Clinical Infectious

More information

Heterosexual men: the HIV minority

Heterosexual men: the HIV minority Heterosexual men: the HIV minority Richard Riley Social Worker Clinical Specialist, HIV John Hunter Hospital 15 March 2013 Outline of session 1. Aims of this session 2. HIV infection rates 3. Transmission,

More information

AUSTRALIAN NSP SURVEY NATIONAL DATA REPORT

AUSTRALIAN NSP SURVEY NATIONAL DATA REPORT Needle Syringe Programs and Harm Reduction Services in Australia AUSTRALIAN NSP SURVEY NATIONAL DATA REPORT - Prevalence of HIV, HCV and injecting and sexual behaviour among NSP attendees The Australian

More information

HIV in hiding: Methods and data requirements for the. estimation of the number of people living with undiagnosed

HIV in hiding: Methods and data requirements for the. estimation of the number of people living with undiagnosed HIV in hiding: Methods and data requirements for the estimation of the number of people living with undiagnosed HIV Working Group on Estimation of HIV Prevalence in Europe* * names listed in Appendix.

More information

Manitoba Health Statistical Update on HIV/AIDS

Manitoba Health Statistical Update on HIV/AIDS Manitoba Health Statistical Update on HIV/AIDS 1985 - Dec 2001 Communicable Disease Control Unit Public Health Branch MANITOBA HEALTH STATISTICAL UPDATE ON HIV/AIDS 1985 TO DECEMBER 2001 HIV January 1,

More information

MANITOBA HIV REPORT 2015

MANITOBA HIV REPORT 2015 MANITOBA HIV REPORT 2015 The Manitoba HIV Program provides information, specialized care, treatment, and support to approximately 1,250 people living with HIV across the province. The Program has two Winnipeg-based

More information

AIDS was described in June 1981 among homosexuals in the USA, and the virus. HIV/AIDS epidemic features and trends in Saudi Arabia

AIDS was described in June 1981 among homosexuals in the USA, and the virus. HIV/AIDS epidemic features and trends in Saudi Arabia ORIGINAL ARTICLE HIV/AIDS epidemic features and trends in Saudi Arabia Yagob Y. Al-Mazrou, PhD, FRCGP; Mohamed H. Al-Jeffri, MSc, DTM&H; Abdulla Ibrahim Fidail, DPH, MPH; Nasir Al-Huzaim, MPH, PhD; Sirrag

More information

Policy Document. Blood Donation Deferral. Background

Policy Document. Blood Donation Deferral. Background Policy Document Blood Donation Deferral Background The Australian Medical Students Association (AMSA) is the peak representative body for medical students in Australia. Accordingly, AMSA advocates on issues

More information

Manitoba Health Statistical Update on HIV/AIDS

Manitoba Health Statistical Update on HIV/AIDS Manitoba Health Statistical Update on HIV/AIDS 1985-2002 Communicable Disease Control Unit Public Health MANITOBA HEALTH STATISTICAL UPDATE ON HIV/AIDS 1985 TO December 2002 HIV January 1, 1985 to December

More information

Data inputs for HIV models and how they inform HIV prevention interventions Dobromir Dimitrov

Data inputs for HIV models and how they inform HIV prevention interventions Dobromir Dimitrov Data inputs for HIV models and how they inform HIV prevention interventions Dobromir Dimitrov Vaccine & Infectious Disease Division Fred Hutchinson Cancer Research Center Dynamic model integration The

More information

Annual Statistical Update on HIV and AIDS 2013

Annual Statistical Update on HIV and AIDS 2013 Annual Statistical Update on HIV and AIDS 2013 Data reported to December 31, 2013 Epidemiology & Surveillance Public Health Branch Public Health and Primary Health Care Division Manitoba Health, Healthy

More information

Annual Statistical Update: HIV and AIDS

Annual Statistical Update: HIV and AIDS Annual Statistical Update: HIV and AIDS 2014 Data reported to December 31, 2014 Epidemiology & Surveillance Public Health Branch Public Health and Primary Health Care Division Manitoba Health, Healthy

More information

HIV Screening & Consent for Testing

HIV Screening & Consent for Testing 1. Algorithm for HIV Screening 2. Screening & Consent for HIV Testing a. Offering testing b. Counseling on HIV Risk Factors c. Pre-test Counseling d. Post-test Counseling 1. Positive Result 2. Preliminary

More information

Clinical Infectious Diseases Advance Access published June 16, Age-Old Questions: When to Start Antiretroviral Therapy and in Whom?

Clinical Infectious Diseases Advance Access published June 16, Age-Old Questions: When to Start Antiretroviral Therapy and in Whom? Clinical Infectious Diseases Advance Access published June 16, 2015 1 Age-Old Questions: When to Start Antiretroviral Therapy and in Whom? Rochelle P. Walensky, Martin S. Hirsch From the Division of Infectious

More information

Summary: Estimates of HIV Prevalence and Incidence in Canada, 2011

Summary: Estimates of HIV Prevalence and Incidence in Canada, 2011 Background Summary: Estimates of HIV Prevalence and Incidence in Canada, 2011 Surveillance and Epidemiology Division Professional Guidelines and Public Health Practice Division Centre for Communicable

More information

Trends in HIV Incidence Among Young Adults in the United States

Trends in HIV Incidence Among Young Adults in the United States Trends in HIV Incidence Among Young Adults in the United States Philip S. Rosenberg, PhD; Robert J. Biggar, MD Context. Behaviors that result in potential exposure to human immunodeficiency virus (HIV)

More information

In-class exercise on Selection Bias Instructor Guide

In-class exercise on Selection Bias Instructor Guide In-class exercise on Selection Bias Instructor Guide Background The HIV epidemic in the United States began in the 1980's through three major sources of transmission: anal sexual intercourse, viral contamination

More information

ECDC update to the EU Commission Think Tank on HIV/AIDS

ECDC update to the EU Commission Think Tank on HIV/AIDS ECDC update to the EU Commission Think Tank on HIV/AIDS Andrew Amato Head of HIV, STI and V. Hepatitis programme, ECDC Luxembourg, 10-11 December 2013 Outline Main ECDC reports published since last Think

More information

Figure 1 Newly diagnosed HIV infection in Australia by yyear. Nu umber. Year. HIV diagnoses. Source: State/Territory health authorities

Figure 1 Newly diagnosed HIV infection in Australia by yyear. Nu umber. Year. HIV diagnoses. Source: State/Territory health authorities Figure 1 Newly diagnosed HIV infection in Australia by yyear 25 2 Nu umber 15 1 5 1984 1986 1988 199 1992 1994 1996 1998 2 22 24 26 28 21 212 HIV diagnoses Source: State/Territory health authorities rate

More information

HIV prevalence and risk behaviors amongst men who have sex with. men in Hong Kong: a systematic review. (Ref. No.: R05-12)

HIV prevalence and risk behaviors amongst men who have sex with. men in Hong Kong: a systematic review. (Ref. No.: R05-12) HIV prevalence and risk behaviors amongst men who have sex with men in Hong Kong: a systematic review (Ref. No.: R05-12) (Report for CUHK I CARE Program 2012 13) Jinghua LI Ph.D. Student School of Public

More information

Thirty years of harm reduction in the Netherlands HCV elimination ahead?

Thirty years of harm reduction in the Netherlands HCV elimination ahead? Thirty years of harm reduction in the Netherlands HCV elimination ahead? Esther Croes, MD PhD Confession 30 years 3 topics: drug use, harm reduction, HCV in 15 minutes IT DOESN T FIT!! 2 Disclosure Esther

More information

HIV in Russia. Cost-effectiveness of Treating Injection Drug Users with Antiretroviral Therapy

HIV in Russia. Cost-effectiveness of Treating Injection Drug Users with Antiretroviral Therapy HIV in Russia Cost-effectiveness of Treating Injection Drug Users with Antiretroviral Therapy Elisa F. Long, M.S. Margaret L. Brandeau, Ph.D. Tatyana Vinichenko, M.D., M.P.A. Cristina M. Galvin, M.S. Swati

More information

HIV and AIDS among Aboriginal peoples in Canada: An Epidemiological Overview

HIV and AIDS among Aboriginal peoples in Canada: An Epidemiological Overview HIV and AIDS among Aboriginal peoples in Canada: An Epidemiological Overview 2011 CAAN AGM Susanna Ogunnaike-Cooke, Jessica Halverson, Chris Archibald Surveillance and Risk Assessment Division Centre for

More information

Evaluating strategies for STI management in remote Indigenous communities of Australia

Evaluating strategies for STI management in remote Indigenous communities of Australia Evaluating strategies for STI management in remote Indigenous communities of Australia STIs in remote Indigenous communities Age group Gonorrhoea prevalence Chlamydia prevalence 16-19 13.5% 17.4% 20-24

More information

Re Joint Committee on Law Enforcement Inquiry into crystal methamphetamine (ice)

Re Joint Committee on Law Enforcement Inquiry into crystal methamphetamine (ice) AUSTRALIAN FEDERATION OF AIDS ORGANISATIONS INC. ABN 91 708 310 631 Committee Secretary Parliamentary Joint Committee on Law Enforcement PO Box 6100 Parliament House Canberra ACT 2600 PO Box 51 Newtown

More information

Treatment as prevention (TasP) Can treatment reduce the transmission of HIV: Experience from the UK

Treatment as prevention (TasP) Can treatment reduce the transmission of HIV: Experience from the UK Treatment as prevention (TasP) Can treatment reduce the transmission of HIV: Experience from the UK Dr Valerie Delpech Health Protection Agency, London (Public Health England) Outline! Brief overview Science,

More information

Type and quantity of data needed for an early estimate of transmissibility when an infectious disease emerges

Type and quantity of data needed for an early estimate of transmissibility when an infectious disease emerges Research articles Type and quantity of data needed for an early estimate of transmissibility when an infectious disease emerges N G Becker (Niels.Becker@anu.edu.au) 1, D Wang 1, M Clements 1 1. National

More information

Challenges and solutions for. life span. June 2011

Challenges and solutions for. life span. June 2011 Challenges and solutions for moving forward to create a healthy life span Consortium Workshop June 2011 Acknowledgements Metro Local Aboriginal Land Council Consortium AHMRC ASHW Network Overview Context

More information

Infectious syphilis in Canada:

Infectious syphilis in Canada: 30 CCDR 05 February 2015 Volume 41-2 https://doi.org/10.14745/ccdr.v41i02a03 Infectious syphilis in Canada: 2003-2012 Totten S 1,*, MacLean R 1, Payne E 1 1 Centre for Communicable Diseases and Infection

More information

Toolbox for conducting integrated HIV bio-behavioral surveillance (IBBS) in key populations Improving health and reducing inequities worldwide

Toolbox for conducting integrated HIV bio-behavioral surveillance (IBBS) in key populations Improving health and reducing inequities worldwide Toolbox for conducting integrated HIV bio-behavioral surveillance (IBBS) in key populations Improving health and reducing inequities worldwide Copyright The Regents of the University of California, 2014.

More information

Survey questionnaire on STI. surveillance, care and prevention. in European countries SAMPLE APPENDIX

Survey questionnaire on STI. surveillance, care and prevention. in European countries SAMPLE APPENDIX European Surveillance of Sexually Transmitted Infections Survey questionnaire on STI surveillance, care and prevention in European countries APPENDIX Detailed questionnaire on clinician and laboratory

More information

Discussion paper: Estimates of the number of people eligible for PrEP in Australia, and related cost-effectiveness.

Discussion paper: Estimates of the number of people eligible for PrEP in Australia, and related cost-effectiveness. Discussion paper: Estimates of the number of people eligible for PrEP in Australia, and related cost-effectiveness. Kirby Institute and the Centre for Social Research in Health UNSW Sydney 2017 Prepared

More information

Exploring the risks of liver cancer after successful treatment for hepatitis C virus

Exploring the risks of liver cancer after successful treatment for hepatitis C virus CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Exploring the risks of liver cancer after successful treatment for hepatitis C virus 11 June 2013 In Canada and other high-income countries,

More information

High prevalence and incidence of HIV and HCV among new injecting drug users with a large proportion of migrants Is prevention failing?

High prevalence and incidence of HIV and HCV among new injecting drug users with a large proportion of migrants Is prevention failing? High prevalence and incidence of HIV and HCV among new injecting drug users with a large proportion of migrants Is prevention failing? Cinta Folch on behalf of REDAN Study Group Viral Hepatitis Prevention

More information

Blood-borne viruses in marginalised populations

Blood-borne viruses in marginalised populations Blood-borne viruses in marginalised populations 2 May 2014 SYDNEY MEDICAL SCHOOL Bethany White, PhD Discipline of Addiction Medicine Overview Blood-borne viruses: HIV Hepatitis B virus (HBV) Hepatitis

More information

Impact of Screening and Treatment for Hepatitis C Virus (HCV) Infection in Switzerland

Impact of Screening and Treatment for Hepatitis C Virus (HCV) Infection in Switzerland 1 Impact of Screening and Treatment for Hepatitis C Virus (HCV) Infection in Switzerland A Comprehensive Mathematical Model of the Swiss HCV Epidemic Final report Janne Estill*, Maryam Sadeghimehr*, Olivia

More information

National Centre in HIV Epidemiology and Clinical Research 2007

National Centre in HIV Epidemiology and Clinical Research 2007 National Centre in HIV Epidemiology and Clinical Research 2007 ISSN 1442 8784 AIHW catalogue number PHE 92 This publication is available at Internet address http://www.nchecr.unsw.edu.au Suggested citation:

More information

Ministry of Health Population Health Branch

Ministry of Health Population Health Branch Ministry of Health Population Health Branch HIV Prevention and Control Report for 2016 saskatchewan.ca Executive Summary The provides an overview of human immunodeficiency virus (HIV) and acquired immune

More information

Copyright Positive Life South Australia Incorporated, 2015.

Copyright Positive Life South Australia Incorporated, 2015. Copyright Positive Life South Australia Incorporated, 2015. Written and compiled by Suzi Quixley & Steven Moran. Recommended citation: Positive Life SA (2015) HIV Basics, Positive Ageing Series #1, Positive

More information

ABSTRACT. of HIV/AIDS. Brandy Rapatski, Doctor of Philosophy, Department of Mathematics

ABSTRACT. of HIV/AIDS. Brandy Rapatski, Doctor of Philosophy, Department of Mathematics ABSTRACT Title of Dissertation: The Non-Linear Transmission Dynamics of HIV/AIDS Brandy Rapatski, Doctor of Philosophy, 2004 Dissertation directed by: Professor James A. Yorke Department of Mathematics

More information

AUSTRALIAN INFLUENZA SURVEILLANCE SUMMARY REPORT

AUSTRALIAN INFLUENZA SURVEILLANCE SUMMARY REPORT AUSTRALIAN INFLUENZA SURVEILLANCE SUMMARY REPORT No.19, 29, REPORTING PERIOD: 12 September 29 18 September 29 Key Indicators The counting of every case of pandemic influenza is no longer feasible in the

More information

Sources of Error. Background

Sources of Error. Background Background Sources of Error The HIV epidemic in the United States began in the 1980's through three major sources of transmission: anal sexual intercourse, viral contamination of blood and blood products,

More information

HIV in the United Kingdom: 2009 Report

HIV in the United Kingdom: 2009 Report HIV in the United Kingdom: 2009 Report Key findings The number of people living with HIV in the UK continues to rise, with an estimated 83,000 infected at the end of 2008, of whom over a quarter (27%)

More information

Gay Community Periodic Survey SYDNEY, February 2008

Gay Community Periodic Survey SYDNEY, February 2008 Gay Community Periodic Survey SYDNEY, February Iryna Zablotska Andrew Frankland Garrett Prestage Ian Down Dermot Ryan National Centre in HIV Social Research National Centre in HIV Epidemiology and Clinical

More information

Report Back from CROI 2010

Report Back from CROI 2010 Report Back from CROI 2010 Conference on Retroviruses and Opportunistic Infections Edwin Charlebois, MPH PhD Associate Professor of Medicine Department of Medicine University of California, San Francisco

More information

Annual Surveillance Report

Annual Surveillance Report 2004 Annual Surveillance Report HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia Edited by National Centre in HIV Epidemiology and Clinical Research National Centre in HIV Epidemiology

More information

Mariza Vono Tancredi. Eliseu Alves Waldman

Mariza Vono Tancredi. Eliseu Alves Waldman Mariza Vono Tancredi Eliseu Alves Waldman RATIONALE The clinical and laboratorial data from a population at a STD/AIDS Referral and Training Center (CRT) in Sao Paulo, Brazil, with 7,853 HIV infected individuals

More information

MEASURING THE UNDIAGNOSED FRACTION:

MEASURING THE UNDIAGNOSED FRACTION: Friday, May 27, 2016 SPRC-PHSKC Lunchbox Talks 1 MEASURING THE UNDIAGNOSED FRACTION: Understanding the UW and CDC back-calculation models Martina Morris, PhD Director, UW CFAR SPRC Jeanette K Birnbaum,

More information